U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Prescription Drug User Fee Amendments
  5. PDUFA Meetings
  1. Prescription Drug User Fee Amendments

PDUFA Meetings

FDA periodically conducts meetings on the Prescription Drug User Fee Act (PDUFA) program. The current legislative authority for PDUFA (PDUFA V), reauthorized in 2012 by the Food and Drug Administration Safety and Innovation Act (FDASIA), will expire in September 2017. The Federal Food, Drug, and Cosmetic Act (FD&C Act) requires that FDA hold public meetings and conduct discussions with both the regulated industry and stakeholder groups in developing recommendations for the next PDUFA program (FY2018-2022).  More information on the upcoming reauthorization effort can be found here:  PDUFA VI

This page contains information for both the public part of the PDUFA reauthorization process and the discussions FDA holds with industry and stakeholders.

PDUFA V Public Meetings

PDUFA IV Public Meetings

Back to Top